China's State Intellectual Property Office issues first patent for novel coronavirus vaccine. This, on Monday, August 17, reports Xinhua. The patent was granted to the Academy of Military Medical Sciences of the People's Liberation Army of China and Can Sino Biologics, which jointly developed a recombinant COVID-19 vaccine based on the Ad5-nCoV adenoviral vector.

As noted, testing in mice and guinea pigs showed that the drug has good immunogenicity.. " Earlier in Russia produced the first batch of its own vaccine against coronavirus. Recall that earlier WHO estimated the cost of drugs for coronavirus. To increase the chances of success in combating the pandemic, it is necessary to create conditions under which the vaccine against COVID-19 will become available " WHO: The World Needs Multiple Kinds of COVID Vaccine News from Telegram. Subscribe to our channel https: // t. me / korrespondentnet Author: 1.